Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

0.5143
Delayed Data
As of Feb 24
 +0.0063 / +1.24%
Today’s Change
0.28
Today|||52-Week Range
1.08
+66.76%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues6.7M18.8M5.6M23.4M
 
 
 
 
 
Cost of Goods Sold3.4M9.1M2.4M14.8M
 
 
 
 
 
Depreciation And Amortization464.0K614.0K613.0K606.0K
 
 
 
 
 
 
Operating ExpensesGross Income2.8M9.1M2.5M7.9M
 
 
 
 
 
General Expenses19.7M21.0M13.6M12.0M
 
 
 
 
 
Research And Development15.2M16.3M8.6M7.0M
 
 
 
 
 
Total Operating Expenses23.6M30.7M16.7M27.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-16.9M-11.9M-11.1M-4.1M
 
 
 
 
 
Other Expenses-14.0K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-16.8M-11.9M-11.1M-4.1M
 
 
 
 
 
Preferred Dividend-1.4M-1.0M-1.4M-1.4M
 
 
 
 
 
Net Income-16.8M-11.9M-11.1M-4.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS227.4M236.9M239.6M244.8M
 
 
 
 
 
Shares To Calculate EPS Diluted227.4M236.9M239.6M244.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.08-$0.05-$0.05-$0.02
 
 
 
 
 
EPS Diluted-$0.08-$0.05-$0.05-$0.02